S Bilgrami
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Hematology 15
- Hematopoietic Stem Cell Transplantation 8
- Multiple Myeloma Research and Treatments 3
- Co-authors
- PJ TutschkaDavid I. DorskyBarbara G. FallonP. J. TutschkaJonathan CliveJay FeingoldJoão L. AscensãoAmir Khan
- Journals
- Bone Marrow Transplantation (11 papers)Acta Haematologica (4 papers)Clinical Infectious Diseases (2 papers)Annals of Pharmacotherapy (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- United States
In The Last Decade
S Bilgrami
38 papers receiving 688 citations
Peers
Comparison fields: 5 of 70
- Hematology 129
- Internal Medicine 41
- Endocrinology 43
- Oncology 218
- Infectious Diseases 140
Countries citing papers authored by S Bilgrami
This map shows the geographic impact of S Bilgrami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Bilgrami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Bilgrami more than expected).
Fields of papers citing papers by S Bilgrami
This network shows the impact of papers produced by S Bilgrami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Bilgrami. The network helps show where S Bilgrami may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S Bilgrami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 16 | |
| 2 | 2001 | 2 | |
| 3 | 2000 | 46 | |
| 4 | 2000 | 25 | |
| 5 | 2000 | 5 | |
| 6 | 2000 | 0 | |
| 7 | 1999 | 70 | |
| 8 | 1999 | 38 | |
| 9 | 1999 | 42 | |
| 10 | 1998 | 36 | |
| 11 | 1997 | 6 | |
| 12 | 1997 | 46 | |
| 13 | 1997 | 8 | |
| 14 | 1995 | 1 | |
| 15 | 1994 | 1 | |
| 16 | 1994 | 18 | |
| 17 | 1993 | 8 | |
| 18 | 1993 | 37 | |
| 19 | 1992 | 34 | |
| 20 | 1991 | 17 |
About S Bilgrami
S Bilgrami is a scholar working on Hematology, Clinical Biochemistry, Endocrinology, Genetics and Internal Medicine, having authored 40 papers that have together received 707 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Polyomavirus and related diseases (5 papers), Neutropenia and Cancer Infections (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Multiple Myeloma Research and Treatments (3 papers), Lung Cancer Research Studies (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Hematology (129 citations), Internal Medicine (41 citations), Endocrinology (43 citations), Oncology (218 citations) and Infectious Diseases (140 citations). S Bilgrami has collaborated with scholars based in United States. Frequent co-authors include PJ Tutschka, David I. Dorsky, Barbara G. Fallon, P. J. Tutschka, Jonathan Clive, Jay Feingold, João L. Ascensão, Amir Khan, Robert Bona and Jaber Aslanzadeh. Their work appears in journals such as Bone Marrow Transplantation, Acta Haematologica, Clinical Infectious Diseases, Annals of Pharmacotherapy and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.